What we can learn from meta-analysis of the clinical trials of cell therapy - CON

20 April 2018 (18:07 - 18:30)

Organised by:

Slides

Sign in to view the resources

About the speaker

Professor Mariann Gyongyosi

Medical University of Vienna, Vienna (Austria)

3 More presentations in this session

Presentation thumbnail

Induced pluripotent stem cells (iPSCs) and their potential in regenerative medicine - PRO

Professor J. Dulak (Krakow, PL)

Presentation thumbnail

Cell therapy for heart disease: unmet expectations - CON

Professor P. Menasche (Paris, FR)

Presentation thumbnail

Cell based therapies for myocardial repair and regeneration in ischaemic heart disease and heart failure - PRO

Associate Professor R. Madonna (Pisa, IT)

Access the full session

Session thumbnail

Controversies in cell therapies for myocardial infarction and heart failure

The Event

Frontiers in CardioVascular Biology 2018

20 April 2018 18:07 CET

You may be interested in

Congress Presentation

Transendocardial injection of autologous expanded CD34+ Stem Cells (ProtheraCytes) promotes reverse cardiac remodeling in patients with left ventricular dysfunction after acute myocardial infarction

14 May 2024

Congress Presentation

The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials

27 August 2021

Congress Presentation

High doses of CD34+ cells delivered to patients in the CardiAMP Heart Failure (HF) trial

29 June 2021

Congress Presentation

Percutaneous coronary intervention versus optimal medical therapy for chronic total occlusion: an updated meta-analysis of randomized controlled trials comparing clinical and health status outcomes

27 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources